Abstract
Aim:
The role of caveolin-1 (Cav-1) in angiogenesis remains poorly understood. The endothelial nitric oxide (NO) synthase (eNOS), a caveolin-interacting protein, was demonstrated to play a predominant role in vascular endothelial growth factor (VEGF) -induced angiogenesis. The purpose of our study was to examine the role of Cav-1 and the eNOS complex in NO-mediated angiogenesis.
Methods:
Human umbilical vein endothelial cells (HUVEC) were isolated and cultured in 3-D fibrin gels to form capillary-like tubules by VEGF stimulation. The expression of Cav-1 and eNOS was detected by semiquantitative RT-PCR. The HUVEC were treated with antisense oligonucleotides to downregulate Cav-1 expression. Both transduced and non-infected HUVEC were cultured in fibrin gels in the presence or absence of VEGF (20 ng/mL) and NG-nitro-L-arginine methyl ester (L-NAME; 5 mmol/L). NO was measured using a NO assay kit and capillary-like tubules were quantified by tubule formation index using the Image J program.
Results:
RT-PCR analysis revealed that Cav-1 levels steadily increased in a time-dependent manner and reached their maximum after 5 d of incubation, but there were no obvious changes in eNOS mRNA expression in response to VEGF in the fibrin gel model. VEGF (20 ng/mL) can promote NO production and the formation of capillary-like tubules, and this promoting effect of VEGF was blocked by the addition of L-NAME (5 mmol/L). When transduced HUVEC with the antisense Cav-1 oligonucleotides were plated in the fibrin gels, the capillary-like tubules were significantly fewer than those of the non-infected cells. The capillary-like tubules formation and NO production of transduced HUVEC with the antisense Cav-1 oligonucleotides cultured in fibrin gels showed no responses to the addition of VEGF (20 ng/mL) and L-NAME (5.0 mmol/L).
Conclusion:
NO was a critical angiogenic mediator in this model. Cav-1 was essential for NO-mediated angiogenesis and may be an important target of anti-angiogenesis therapy.
Similar content being viewed by others
Article PDF
References
Okamoto T, Schlegel A, Scherer PE, Lisanti MP . Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane. J Biol Chem 1998; 273: 5419–22.
Hanahan D, Folkman J . Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis. Cell 1996; 86: 353–64.
Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O . Hsp 90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 2001; 89: 866–73.
Bauer PM, Yu J, Chen Y, Hickey R, Bernatchez PN, Looft-Wilson R, et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci USA 2005; 102: 204–9.
Liu J, Razani B, Tang S, Terman BI, Ware A, Lisanti MP . Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. J Biol Chem 1999; 274: 15781–5.
Luo JD, Chen AF . Nitric oxide: a newly discovered function on wound healing. Acta Pharmacol Sin 2005; 26: 259–64.
Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 2001; 98: 2604–9.
Gratton JP, Lin MI, Yu J, Weiss ED, Jiang ZL, Fairchild TA, et al. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 2003; 4: 31–9.
Hood JD, Meininger CJ, Ziche M, Granger HJ . VEGF upregulates eNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274: H1054–8.
van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030–7.
Alexandrova R, Mileva M, Zvetkova E . Nitric oxide and cancer (mini review). Exp Pathol Parasitol 2001; 4: 13–8.
Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, Stewart DJ . Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 1998; 82: 1007–15.
Phillips PG, Birnby LM . Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface. Am J Physiol Lung Cell Mol Physiol 2004; 286: L1055–65.
Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Perez-del-Pulgar S, et al. Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of bibroblasts and angiopoietn-1. Microvas Res 2003; 66: 102–12.
Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, Maragoudakis ME . Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 1994; 111: 894–902.
Dimmeler S, Hermann C, Galle J, Zeiher AM . Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 1999; 19: 656–64.
Ziche M, Parenti A, Ledda F, Dell'Era P, Granger HJ, Maggi CA, et al. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res 1997; 80: 845–52.
Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, et al. Nitric oxide mediates angiogenesis in vivo and endot-helial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036–44.
Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC . NO production contributes to the angiogenic properties of VEGF in human endothelial cells. J Clin Invest 1997; 100: 3131–9.
Frank PG, Woodman SE, Park DS, Lisanti MP . Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol 2003; 23: 1161–8.
Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K . Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 2003; 13: 92–100.
Feron O, Kelly RA . The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ Res 2001; 88: 129–31.
Feron O, Michel JB, Sase K, Michel T . Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry 1998; 37: 193–200.
Li H, Brodsky S, Basco M, Romanov V, De Angelis DA, Goligorsky MS . Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circ Res 2001; 88: 229–36.
Miyawaki-Shimizu K, Predescu D, Shimizu J, Broman M, Predescu S, Malik AB . siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability Via the junctional pathway. 2006; 290: L405–13.
Sonveau X, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, et al. Caveolin-1 expression is critical for VEGF-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circ Res 2004; 95: 154–61.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by grants from the Personnel Department of Jiangsu Province, China (No C-2002-012).
Rights and permissions
About this article
Cite this article
Pan, Ym., Yao, Yz., Zhu, Zh. et al. Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells. Acta Pharmacol Sin 27, 1567–1574 (2006). https://doi.org/10.1111/j.1745-7254.2006.00462.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00462.x
Keywords
This article is cited by
-
A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke
Journal of Neuroinflammation (2018)
-
Geniposide inhibits high glucose-induced cell adhesion through the NF-κB signaling pathway in human umbilical vein endothelial cells
Acta Pharmacologica Sinica (2010)
-
Genipin inhibits endothelial exocytosis via nitric oxide in cultured human umbilical vein endothelial cells
Acta Pharmacologica Sinica (2009)